BaseSpace
Import Your Data
QuickView

FAQ

More QuickView FAQs

Back to top
Clear Search sequence regions
(e.g. Allergy to pollen, Hypothalamus, Nosology, Rapamycin, rs2230926, CYP51)
Bookmark Forward

QuickView for Conjugated Estrogens (compound)


Genetic Markers

Most Correlated Genes

  1. ESR1
  2. OVOS2
  3. SPP1
  4. TMPRSS3
  5. LGR5
Explore Genetic Markers Results

Pathway Enrichment

Most Correlated Biogroups

  1. SMID_BREAST_CANCER_LUMINAL_A_UP
  2. GSE26030_TH1_VS_TH17_DAY15_POST_POLARIZATION_DN
  3. SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP
  4. BOQUEST_STEM_CELL_UP
  5. CHEN_METABOLIC_SYNDROM_NETWORK
Explore Pathway Enrichment Results

Curated Studies

Most Correlated Studies

  1. Vaginal tissue swabs of postmenopausal women with estrogen replacement therapy
  2. Mammary tissues from cynomolgus monkeys after 2-year hormone replacement therapy
  3. Drug target sets for approved compounds
Explore Curated Studies Results

Literature

Most Relevant Literature

  1. Breast density changes in a randomized controlled trial evaluating bazedoxifene/conjugated estrogens…
  2. Hot flush symptom-free days with bazedoxifene/conjugated estrogens in postmenopausal women.
  3. Using bazedoxifene plus conjugated estrogens for treating postmenopausal women: a comprehensive rev…
  4. Bazedoxifene/conjugated estrogens for menopausal symptom treatment and osteoporosis prevention.
  5. Skeletal effects of bazedoxifene paired with conjugated estrogens in ovariectomized rats.
Explore Literature Results

Clinical Trials

Most Relevant Clinical Trials

  1. Ospemifene vs. Conjugated Estrogens in the Treatment of Postmenopausal Sexual Dysfunction
  2. Phase IIB Trial of Bazedoxifene Plus Conjugated Estrogens
  3. Pilot Study of Bazedoxifene Plus Conjugated Estrogen on Imaging and Blood Biomarkers
  4. Bioequivalence Study Of Bazedoxifene/Conjugated Estrogen Tablets In Postmenopausal Women
  5. Study Evaluating Bazedoxifene/Conjugated Estrogens Combinations In Postmenopausal Women
Explore Clinical Trials Results
  • Copyright © 2024 Illumina Inc. All rights reserved.